<DOC>
	<DOCNO>NCT02083549</DOCNO>
	<brief_summary>The purpose study evaluate efficacy University Rochester Medical Center 's current Massive Transfusion Protocol . Upon arrival trauma level one designate patient treat team evaluate patient 's injury . If patient initiate facility Massive Transfusion Protocol meet inclusion exclusion criterion patient enrol study . Study procedure include collection blood sample follow transfusion shipment , shipment 5 , blood product outline current Massive Transfusion Protocol . Each blood sample run Thromboelastograph evaluate patient 's hematostatic state resuscitation . One final blood sample collect 24 hour follow discontinuation Massive Transfusion Protocol also run thromboelastograph . Due critical need medical intervention , consent procedure waive time enrollment . An authorized representative patient identify approached obtain consent use data collect .</brief_summary>
	<brief_title>Evaluating URMC 's Massive Transfusion Protocol</brief_title>
	<detailed_description />
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>Trauma level 1 patient initiate Massive Transfusion Protocol Age great equal 18 year old Females pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Massive Transfusion Protocol</keyword>
</DOC>